A 2023 systematic review of 27 studies found molecular hydrogen improved survival rates, reduced chemotherapy side effects, and slowed tumour growth across multiple cancer types — positioning H₂ therapy as a meaningful complement to conventional cancer care.
Alzheimer's Drug Discovery Foundation (ADDF) — Cognitive Vitality Report
A review of the current evidence on molecular hydrogen and brain health — covering stroke recovery, traumatic brain injury, vascular dementia, and cognitive aging. What the research shows, and what it doesn't.
A 2023 review in Biomedicine & Pharmacotherapy examined hydrogen therapy across multiple mechanisms relevant to Alzheimer's disease — from amyloid reduction and neuroinflammation to mitochondrial support. Here is what the evidence currently shows.
A 2019 review in Frontiers in Oncology examined hydrogen gas across preclinical and early clinical cancer research — covering side effect reduction, organ protection, and direct anti-tumour effects. Here is what the evidence shows.
